Disease detection at an early stage is one of the
biggest challenges biochemists and materials scientists are trying
to meet by combining their expertise at Missouri S&T. The
researchers used nanotechnology in biomedical diagnostics—a process
called nanodiagnostics—to create a new, ultrasensitive DNA
biosensor. The new sensor could potentially detect DNA-based
biomarkers for early diagnosis of cancer and genetic disorders, as
well as monitor patient responses to therapies.
Researchers create unique DNA biosensor for early stage
disease detection

